close

Enter

Log in using OpenID

Actinic Keratosis Market

embed
Actinic keratosis (AK), referred as solar keratosis is a scaly and crusty growth caused by the damage from exposure to ultraviolet (UV) radiation.
Actinic Keratosis Market Trends, Outlook, and
Opportunity Analysis, 2018 – 2026
Actinic keratosis (AK), referred as solar keratosis is a scaly and crusty growth caused by the
damage from exposure to ultraviolet (UV) radiation. These precancerous skin lesions appear on
the skin frequently exposed to the artificial sources of UV light, such as tanning machines or
the sun. The skin lesions appear elevated, rough textured, and resemble warts. Actinic keratosis
reflects abnormal skin cell development, due to DNA damage by short wavelength ultraviolet B
(UVB). Individuals working with polycyclic aromatic hydrocarbons (PAHs), such as coal or tar
are at a higher risk of getting AKs, as they are mostly exposed to the UV rays and tar. A small
percentage of actinic keratosis lesions have the potential to eventually culminate into a type of
skin cancer known as squamous cell carcinoma. Prevention of actinic keratosis is important, as
the condition can precede cancer or be an early form of skin cancer. Skin biopsy is indicated
for the conformation of the diagnosis and to eradicate invasive squamous cell carcinoma for the
advanced lesions.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1006
Increasing complications associated with actinic keratosis is expected to fuel the actinic keratosis
market
The treatment of actinic keratosis as a part of preventive strategy for the reduction of
interrelated disorders, such as non-melanoma skin cancer, squamous cell carcinoma, and basal
cell carcinoma is coming to the forefront. According to the U.S. National Library of Medicine,
2015, approximately 60% of squamous cell carcinomas of the skin probably arise from actinic
keratosis. Therefore, the rising incidences of skin cancers, such as intra epidermal squamous cell
carcinoma, invasive cutaneous squamous cell carcinoma, basal cell carcinoma, and melanoma is
expected to augment the market growth. Moreover, the wide presence and easy availability of
generic drugs for the treatment for actinic keratosis is expected to boost the market growth.
However, lack of medical awareness about the skin condition, available treatments, and delayed
diagnosis are some of the factors restraining the global actinic keratosis market.
Report includes chapters which deeply display the following deliverable about industry :
• Actinic Keratosis Market Research Objective and Assumption
• Actinic Keratosis Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Actinic Keratosis Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Actinic Keratosis Market , By Regions
• Actinic Keratosis Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Actinic Keratosis Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Actinic Keratosis Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Actinic Keratosis Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Commitment of major players to develop the effective photodynamic therapy to rise the demand
for actinic keratosis treatment
The key players operating the actinic keratosis market are DUSA Pharmaceuticals, Inc., Tolmar
Pharmaceuticals, Inc., Perrigo Company plc, Valeant Pharmaceuticals International, Inc., Aqua
Pharmaceuticals, LLC, Galderma SA, LEO Laboratories, and Apotex. The major manufacturers
are committed to developing innovative products that can effectively manage skin conditions,
such as actinic keratosis (AKs). For instance, actinic keratosis treatment with Levulan Kerastick
and BLU-U photodynamic therapy illuminator with blue light illumination introduced by DUSA
Pharmaceuticals, Inc. is indicated for the treatment of minimally to moderately thick actinic
keratosis of the face or scalp.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/actinic-keratosis-market-1006
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge244   documents Email
Document
Category
Health and Medicine
Views
10
File Size
107 KB
Tags
Actinic Keratosis Market, market
1/--pages
Report inappropriate content